Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $852.72 | 25 | 94.0% |
| Education | $54.26 | 4 | 6.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BOSTON SCIENTIFIC CORPORATION | $389.76 | 15 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $157.55 | 3 | $0 (2024) |
| Axonics, Inc. | $136.10 | 2 | $0 (2023) |
| Aroa Biosurgery Incorporated | $74.58 | 1 | $0 (2024) |
| Becton, Dickinson and Company | $32.38 | 1 | $0 (2024) |
| PFIZER INC. | $29.26 | 2 | $0 (2018) |
| Allergan, Inc. | $28.62 | 2 | $0 (2021) |
| Davol Inc. | $23.92 | 1 | $0 (2022) |
| Ambu Inc. | $18.81 | 1 | $0 (2024) |
| NeoTract Inc. | $16.00 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $269.73 | 5 | AstraZeneca Pharmaceuticals LP ($143.96) |
| 2023 | $136.10 | 2 | Axonics, Inc. ($136.10) |
| 2022 | $23.92 | 1 | Davol Inc. ($23.92) |
| 2021 | $230.17 | 3 | BOSTON SCIENTIFIC CORPORATION ($218.01) |
| 2020 | $19.14 | 1 | Boston Scientific Corporation ($19.14) |
| 2019 | $79.72 | 6 | Boston Scientific Corporation ($66.13) |
| 2018 | $109.49 | 8 | BOSTON SCIENTIFIC CORPORATION ($63.77) |
| 2017 | $38.71 | 3 | BOSTON SCIENTIFIC CORPORATION ($22.71) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/16/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Education | In-kind items and services | $9.00 | General |
| Category: Rare Disease | ||||||
| 09/12/2024 | Aroa Biosurgery Incorporated | — | Food and Beverage | Cash or cash equivalent | $74.58 | General |
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $134.96 | General |
| Category: Rare Disease | ||||||
| 07/25/2024 | Becton, Dickinson and Company | Phasix Mesh (Device) | Food and Beverage | In-kind items and services | $32.38 | General |
| Category: Surgery | ||||||
| 07/02/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $18.81 | General |
| 04/26/2023 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $125.78 | General |
| Category: Urology | ||||||
| 04/26/2023 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $10.32 | General |
| Category: Urology | ||||||
| 03/30/2022 | Davol Inc. | — | Food and Beverage | In-kind items and services | $23.92 | General |
| 06/16/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: HYPERHYDROSIS | ||||||
| 03/05/2021 | BOSTON SCIENTIFIC CORPORATION | GENERAL ERECTILE DYSFUNCTION (Device) | Food and Beverage | In-kind items and services | $102.81 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/04/2021 | BOSTON SCIENTIFIC CORPORATION | GENERAL ERECTILE DYSFUNCTION (Device) | Food and Beverage | In-kind items and services | $115.20 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/16/2020 | Boston Scientific Corporation | GENERAL - THERAPIES (Device) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: THERAPIES | ||||||
| 12/03/2019 | Boston Scientific Corporation | GENERAL ERECTILE DYSFUNCTION (Device) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: ERECTILE DYSFUNCTION | ||||||
| 11/12/2019 | Boston Scientific Corporation | GENERAL ERECTILE DYSFUNCTION (Device) | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: ERECTILE DYSFUNCTION | ||||||
| 06/11/2019 | Boston Scientific Corporation | GENERAL ERECTILE DYSFUNCTION (Device) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: ERECTILE DYSFUNCTION | ||||||
| 05/09/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/12/2019 | Boston Scientific Corporation | GENERAL ERECTILE DYSFUNCTION (Device) | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: ERECTILE DYSFUNCTION | ||||||
| 02/05/2019 | Boston Scientific Corporation | GENERAL ERECTILE DYSFUNCTION (Device) | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: ERECTILE DYSFUNCTION | ||||||
| 12/11/2018 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2018 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 10/30/2018 | BOSTON SCIENTIFIC CORPORATION | GENERAL ERECTILE DYSFUNCTION (Device) | Food and Beverage | In-kind items and services | $10.98 | General |
| Category: ERECTILE DYSFUNCTION | ||||||
| 05/24/2018 | Allergan Inc. | BOTOX THERAPEUTIC (Biological) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: HYPERHYDROSIS | ||||||
| 05/22/2018 | BOSTON SCIENTIFIC CORPORATION | GENERAL ERECTILE DYSFUNCTION (Device) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: ERECTILE DYSFUNCTION | ||||||
| 04/10/2018 | BOSTON SCIENTIFIC CORPORATION | GENERAL ERECTILE DYSFUNCTION (Device) | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: ERECTILE DYSFUNCTION | ||||||
| 04/03/2018 | BOSTON SCIENTIFIC CORPORATION | GENERAL ERECTILE DYSFUNCTION (Device) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: ERECTILE DYSFUNCTION | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,705 | 2,044 | $392,192 | $107,856 |
| 2022 | 22 | 1,939 | 4,380 | $470,021 | $130,573 |
| 2021 | 28 | 2,300 | 2,772 | $474,276 | $129,723 |
| 2020 | 25 | 2,480 | 3,051 | $440,377 | $112,218 |
All Medicare Procedures & Services
101 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 24 | 180 | $141,747 | $24,593 | 17.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 109 | 114 | $64,752 | $18,555 | 28.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 277 | 308 | $37,830 | $17,772 | 47.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 147 | 164 | $28,832 | $13,959 | 48.4% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 162 | 162 | $18,630 | $7,776 | 41.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 116 | 137 | $10,162 | $4,371 | 43.0% |
| 51729 | Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | Office | 2023 | 25 | 25 | $10,610 | $3,134 | 29.5% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 19 | 19 | $10,361 | $3,042 | 29.4% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 11 | 41 | $12,874 | $2,390 | 18.6% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 24 | 24 | $7,807 | $2,306 | 29.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $5,012 | $2,046 | 40.8% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 267 | 302 | $16,006 | $1,974 | 12.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 33 | 33 | $5,518 | $1,923 | 34.9% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 25 | 25 | $4,592 | $1,190 | 25.9% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 22 | 24 | $8,245 | $992.45 | 12.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 266 | 293 | $3,516 | $644.60 | 18.3% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 23 | 29 | $1,624 | $608.84 | 37.5% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 102 | 111 | $1,708 | $345.21 | 20.2% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2023 | 11 | 11 | $1,577 | $156.09 | 9.9% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 22 | 22 | $789.00 | $77.63 | 9.8% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 21 | 187 | $161,009 | $26,292 | 16.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 310 | 373 | $42,522 | $21,598 | 50.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 85 | 97 | $55,096 | $15,952 | 29.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 119 | 133 | $21,679 | $11,436 | 52.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 166 | 166 | $19,090 | $7,664 | 40.1% |
About Dr. Robert Johnson, MD
Dr. Robert Johnson, MD is a Urology healthcare provider based in Springfield, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1841330412.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Johnson, MD has received a total of $906.98 in payments from pharmaceutical and medical device companies, with $269.73 received in 2024. These payments were reported across 29 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($852.72).
As a Medicare-enrolled provider, Johnson has provided services to 8,424 Medicare beneficiaries, totaling 12,247 services with total Medicare billing of $480,371. Data is available for 4 years (2020–2023), covering 101 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Springfield, MO
- Active Since 02/06/2007
- Last Updated 09/08/2010
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1841330412
Products in Payments
- GENERAL ERECTILE DYSFUNCTION (Device) $218.01
- ANDEXXA (Biological) $143.96
- Axonics (Device) $136.10
- GENERAL ERECTILE DYSFUNCTION (Device) $66.13
- GENERAL ERECTILE DYSFUNCTION (Device) $63.77
- Phasix Mesh (Device) $32.38
- XTANDI (Drug) $29.26
- GENERAL - ERECTILE DYSFUNCTION (Device) $22.71
- GENERAL - THERAPIES (Device) $19.14
- BOTOX THERAPEUTIC (Biological) $16.46
- Urolift - UL400 (Device) $16.00
- IMFINZI (Drug) $13.59
- BOTOX (Biological) $12.16
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Springfield
Bryan Mehlhaff, Md, MD
Urology — Payments: $1.5M
Kevin Mcvary, Md, MD
Urology — Payments: $405,504
Bradley Schwartz, M.d, M.D
Urology — Payments: $105,537
Robert Nadler, Md, MD
Urology — Payments: $93,691
Kevin Krughoff
Urology — Payments: $54,104
Dr. Eric Espinosa
Urology — Payments: $23,023